Generated Summary
This document is a statement of concern from the Canadian Public Health Association (CPHA) regarding the use of medically-important antimicrobial compounds in animal agriculture. It outlines the CPHA’s concerns about the continuing use of antimicrobials for prophylaxis and growth promotion in animal agriculture, based on scientific evidence linking this practice to antimicrobial resistance (AMR) in healthcare. The document recommends restricting the use of antimicrobials in animal agriculture to the treatment of disease under veterinary supervision, rescinding the “own use” provision for importing antimicrobials, and implementing surveillance activities to identify the types and extent of antimicrobial use. The document reviews the background of AMR, providing examples of increasing resistance and associated healthcare costs. It highlights recent developments and scientific evidence that demonstrate the negative impacts of overuse of antimicrobials in food production animals, including the horizontal transfer of AMR genes and the emergence of pan-resistant microorganisms. The document refers to the WHO report released in 2011 describing an “urgent need for action remediating antibiotic resistance through a holistic, inter-sectoral and multifaceted approach.” It also reviews the current status of antimicrobial use in animal agriculture and provides examples of policy changes in other countries and provinces in Canada. The document’s recommendations and discussion highlight the urgent need for veterinary oversight, restrictions on the use of medically important antimicrobials, and the development of surveillance systems to monitor antimicrobial use in Canadian food animal production.
Key Findings & Statistics
- Infections with Methicillin-resistant Staphylococcus aureus (MRSA) doubled from 4.2 cases per 1000 in 2001 to 8.5 per 1000 in 2007.
- Estimated direct healthcare costs associated with MRSA and AMR enteric bacteria are $104 million to $187 million annually.
- A recent Danish study found that 11% of slaughter pigs had fecal samples positive for extended-spectrum cephalosporin-resistant E. coli.
- A Dutch study demonstrated that 39% of multi-drug resistant E. coli found in poultry samples belonged to identical genotypes present in human clinical samples.
- In Canada, about 88% of the total volume (by weight of active ingredient) of antimicrobials distributed for sale are for use in animals.
- Only two systemic antibacterial agents have been approved for use in humans by the U.S. FDA since 2008, compared to sixteen that were approved from 1983-1987.
Other Important Findings
- The CPHA is concerned about the use of antimicrobial compounds for prophylaxis and growth promotion in animal agriculture.
- Scientific evidence indicates a linkage between the use of antimicrobials in animal agriculture and antimicrobial resistance in healthcare.
- Bacteria can transfer their genetic resistance traits to the normal intestinal flora of animals and humans.
- Human, animal and environmental strains of multi-drug resistant E. coli displayed high clonal diversity but harbored indistinguishable plasmids.
- The World Health Organization (WHO) released a report describing an “urgent need for action remediating antibiotic resistance through a holistic, inter-sectoral and multifaceted approach.”
- Sweden, Denmark, and the European Union have banned non-therapeutic use of some or all antimicrobials for animal production.
- The US Food and Drug Administration (FDA) asked the food animal-production industry to voluntarily adopt recommendations limiting the use of medically-important antimicrobial drugs.
- Health Canada’s policy on Extra-Label Drug Use (ELDU) recommends veterinary oversight when using medically important antimicrobials.
- In Quebec, access to antibiotics for food-producing animals is through veterinary prescription and supervision.
- The Ontario Medical Association (OMA) and Community Hospital Infection Control Association have called for reductions of the use of antimicrobial compounds in animal husbandry.
- Initial economic analyses indicate that the use of antibiotics in animal husbandry may not be cost effective.
Limitations Noted in the Document
- The document is a statement of concern and does not present original research data, thus having limitations in terms of primary research-based findings.
- The document acknowledges the limited number of new antibiotics in development, which complicates solutions to AMR.
- The economic information regarding the costs and benefits of antibiotic use for prophylaxis and growth promotion in animal husbandry is limited.
- The document points out that there is a lack of surveillance information concerning the use of anti-microbial compounds in animal husbandry.
- The analysis of US animal agricultural practices is mentioned, but further details about the scope or limitations of these analyses are not provided.
- The reliance on secondary sources and existing scientific literature introduces limitations.
Conclusion
The CPHA’s statement underscores the pressing need to address the overuse of antimicrobials in animal agriculture to mitigate the rising threat of antimicrobial resistance. The core argument revolves around the scientifically established link between the use of these compounds in animal agriculture and the increasing resistance in healthcare. The document’s recommendations are clear: prioritize veterinary oversight, limit the use of medically important antimicrobials for non-therapeutic purposes, and develop comprehensive surveillance systems. These steps are crucial for safeguarding both animal and human health. The document highlights the emergence of pan-resistant microorganisms and the need for urgent action. The document’s call for the removal of the “own use” provision underscores the need for stricter regulations. It is worth noting that the document also points to the economic inefficiency of using antibiotics in animal husbandry and that the net value of flocks could be increased by withdrawing prophylactic antimicrobials. The CPHA’s conclusion advocates for a cautious approach in animal husbandry similar to that used in human medicine. The implications of this statement are far-reaching, emphasizing the importance of a One Health approach where human, animal, and environmental health are considered interconnected. The call for the development of a surveillance system and the removal of the ‘own use’ provision are paramount for effectively addressing the scope of antimicrobial resistance. By implementing these recommendations, Canada can take significant steps toward protecting both animal and human health and ensuring the continued effectiveness of critical antimicrobial drugs.